Quarterly report pursuant to Section 13 or 15(d)

10. SEGMENTS (Details)

v3.19.1
10. SEGMENTS (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Revenues $ 3,528,589 $ 4,042,006  
Cost of product revenue 9,405,179 12,242,748  
(Loss) income from operations (13,208,416) (16,532,503)  
Interest and other (expense) income, net (1,424,465) (1,289,639)  
Gain on transfer of plasma center assets 11,527,421 0  
Loss on extinguishment of debt (9,962,495) 0  
Net (loss) income (13,067,955) (17,822,142)  
Purchase of property and equipment 110,453 549,246  
Depreciation and amortization expense 805,330 829,541  
Total assets 78,119,970 91,137,625 $ 88,876,521
ADMA BioManufacturing      
Revenues 1,343,983 1,666,243  
Cost of product revenue 7,940,346 10,697,642  
(Loss) income from operations (10,620,807) (12,724,718)  
Interest and other (expense) income, net (169,613) (240,054)  
Gain on transfer of plasma center assets 0    
Loss on extinguishment of debt 0    
Net (loss) income (10,790,420) (12,964,772)  
Purchase of property and equipment 110,453 105,199  
Depreciation and amortization expense 687,393 631,832  
Total assets 57,529,070 47,481,781  
Plasma Collection Centers      
Revenues 2,148,898 2,340,055  
Cost of product revenue 1,464,833 1,545,106  
(Loss) income from operations 29,579 (1,038,824)  
Interest and other (expense) income, net 13,620 (435)  
Gain on transfer of plasma center assets 11,527,421    
Loss on extinguishment of debt 0    
Net (loss) income 11,570,620 (1,039,259)  
Purchase of property and equipment 0 444,047  
Depreciation and amortization expense 114,241 188,914  
Total assets 4,038,367 27,532,613  
Corporate      
Revenues 35,708 35,708  
Cost of product revenue 0 0  
(Loss) income from operations (2,617,188) (2,768,961)  
Interest and other (expense) income, net (1,268,472) (1,049,150)  
Gain on transfer of plasma center assets 0    
Loss on extinguishment of debt (9,962,495)    
Net (loss) income (13,848,155) (3,818,111)  
Purchase of property and equipment 0 0  
Depreciation and amortization expense 3,696 8,795  
Total assets $ 16,552,533 $ 16,123,231